PATENT CLAIM ANALYSIS

Application Number: 16109508
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2018-12
Patent Classification: ["702", "019000"]

Abstract:
A dosing controller for administering insulin. The dosing controller includes a data processing device and non-transitory memory in communication with the data processing device. The dosing controller receives blood glucose measurements of a patient from the glucometer, receives patient information, selects a subcutaneous insulin treatment from a collection of subcutaneous insulin treatments based on the blood glucose measurements and the patient information, and executes the selected subcutaneous insulin treatment. Each blood glucose measurement is separated by a time interval and includes a blood glucose time associated with a time of measuring the blood glucose measurement.

Claim (Index 8):
The dosing controller of  claim 4 , wherein the operations further comprise:\n determining for a given blood glucose time within a second sequential time interval of the four sequential time intervals or a third sequential time interval of the six sequential time intervals, a given blood glucose measurement that is within one of a plurality of target ranges of values; determining a basal dose adjustment factor for adjusting a current day recommended basal dose for administration to the patient based on the corresponding target range of values and the given blood glucose measurement; retrieving a previous day recommended basal dose; determining a new value of the current day recommended basal dose by multiplying the basal adjustment factor times the previous day recommended basal dose; and administering the value of the current day's recommended basal dose to the patient by transmitting the value of the current day's recommended basal dose from the data processing device to the dose administering system having the patient display, the patient display configured to display a third number of units of insulin corresponding to the value of the current day's recommended basal dose and trigger administration of the third number of units of insulin to the patient at a configurable frequency of one, two, or three times per day.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 96.0
- Lexical Diversity: 2.125
- Patent Class: 702.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14524756', '15862310', '14938997', '15942740', '14524918']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.3693691217160804
- 35 USC 102 Novelty (BERT): 0.6726020454830411
- Combined Prediction Score: 0.3996924140927765
- Mean Citation Score: 664.9779000000002
- Max Citation Score: 694.5615
- Similarity Product: 653.0488922089935

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test